First Command Bank’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$195K Hold
1,602
0.02% 143
2023
Q1
$246K Hold
1,602
0.03% 116
2022
Q4
$288K Hold
1,602
0.04% 99
2022
Q3
$189K Sell
1,602
-250
-13% -$37.9K 0.03% 126
2022
Q2
$265K Hold
1,852
0.04% 100
2022
Q1
$319K Buy
1,852
+467
+34% +$78.6K 0.04% 102
2021
Q4
$533K Hold
1,385
0.09% 83
2021
Q3
$533K Hold
1,385
0.09% 83
2021
Q2
$325K Buy
1,385
+385
+39% +$68.8K 0.04% 108
2021
Q1
$131K Sell
1,000
-216
-18% -$31.3K 0.03% 154
2020
Q4
$127K Buy
1,216
+216
+22% +$21.9K 0.03% 145
2020
Q3
$71K Buy
+1,000
New +$69.7K 0.02% 170

Other funds holding MRNA

First Command Bank's MRNA Position: Q2 2023 in Review

First Command Bank held its Moderna (MRNA) position steady in Q2 2023 at 1,602 shares worth $195K. The position accounts for 0.02% of the portfolio, ranked #143.

First Command Bank first reported a position in MRNA in Q3 2020 and has held it in 12 quarters since. The position peaked at $533K in Q4 2021. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • First Command Bank held 1,602 shares of Moderna worth $195K as of Q2 2023.
  • First Command Bank left its Moderna share count unchanged in Q2 2023.
  • Moderna made up 0.02% of First Command Bank's portfolio in Q2 2023, its #143 holding.
  • First Command Bank first reported a position in Moderna in Q3 2020 and has held it in 12 quarters since.
  • First Command Bank's Moderna position peaked at $533K in Q4 2021.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on First Command Bank's 13F filing for Q2 2023, filed 21 Jul 2023.